JMPWA
LOXO

JP Morgan Private Wealth Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,343
Closed -$742K – 1638
2018
Q3 		$742K Sell
4,343
-14
-0.3% -$2.35K ﹤0.01% 929
2018
Q2 		$756K Buy
4,357
+7
+0.2% +$1.05K ﹤0.01% 867
2018
Q1 		$502K Sell
4,350
-450
-9% -$47.9K ﹤0.01% 873
2017
Q4 		$404K Buy
4,800
+55
+1% +$4.59K ﹤0.01% 947
2017
Q3 		$437K Buy
4,745
+45
+1% +$3.5K ﹤0.01% 900
2017
Q2 		$377K Buy
+4,700
New +$260K ﹤0.01% 927

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Private Wealth Advisors's LOXO Position: Q4 2018 in Review

JP Morgan Private Wealth Advisors sold out of Loxo Oncology, Inc (LOXO) in Q4 2018, closing a stake of 4,343 shares — an estimated $742K sold.

JP Morgan Private Wealth Advisors first reported a position in LOXO in Q2 2017 and held it in 6 quarters. The position peaked at $756K in Q2 2018. 232 funds tracked by Wall St. Rank hold LOXO as of Q4 2018.

  • JP Morgan Private Wealth Advisors reported no remaining Loxo Oncology, Inc position as of Q4 2018 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 4,343 Loxo Oncology, Inc shares in Q4 2018, an estimated $742K.
  • JP Morgan Private Wealth Advisors first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 6 quarters.
  • JP Morgan Private Wealth Advisors's Loxo Oncology, Inc position peaked at $756K in Q2 2018.
  • 232 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2018.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.